PerkinElmer to Pay Quarterly Dividend | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer announced that its board of directors has declared a quarterly dividend of $.07 per share.

The Waltham, Mass.-based firm said that the dividend is payable on Aug. 13 to all shareholders of record at the close of business on July 23.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.